Patents by Inventor David Segev

David Segev has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10432654
    Abstract: Method and system for detecting an unknown undesirable event, such as (but not limited to) a cyber-threat, a cyber-intrusion, a financial fraud event or a monitored process malfunction of breakdown. An exemplary method embodiment comprises obtaining a dataset comprising a plurality n of multidimensional data points with a dimension m?2 wherein each data point is a vector of m features, processing the MDPs using measure-based diffusion maps to embed the MDPs into a lower dimension embedded space, and detecting in the embedded space an abnormal MDP without relying on a signature of a threat, the abnormal MDP being indicative of the unknown undesirable event.
    Type: Grant
    Filed: August 22, 2018
    Date of Patent: October 1, 2019
    Assignee: ThetaRay Ltd.
    Inventors: Amir Averbuch, Gil Shabat, Erez Shabat, David Segev
  • Patent number: 10419470
    Abstract: A computer program product for performing anomaly detection, a detected anomaly being indicative of an undesirable event, the computer program product comprising a non-transitory tangible storage medium readable by a processing circuit and storing instructions for execution by the processing circuit for performing a method comprising receiving data comprising a plurality m of multidimensional datapoints (MDDPs), each data point having n features, constructing a dictionary D based on the received data, embedding dictionary D into a reduced dimension embedded space and classifying, based in the reduced dimension embedded space, an MDDP as an anomaly or as normal.
    Type: Grant
    Filed: November 25, 2018
    Date of Patent: September 17, 2019
    Assignee: ThetaRay Ltd
    Inventors: David Segev, Gil Shabat
  • Patent number: 10296832
    Abstract: A system for detecting an unknown undesirable event comprises an input device configured to receive a dataset comprising a plurality n of multidimensional datapoints (MDDPs), a processor configured to embed the MDDPs in an lower dimension embedded space to obtain embedded MDDPs, and a detection engine configured to calculate distributions of distances Dnni, i=1, . . . , n of each embedded MDDP from a plurality of nearest-neighbors (nn) to compute a threshold Dnnt and to classify a particular MDDP of the dataset or a newly arrived MDDP (NAMDDP) as an abnormal MDDP based on comparison with threshold Dnnt, wherein the classification is automatic and unsupervised without relying on a signature, rules or domain expertise and wherein the particular MDDP classified as abnormal is indicative of the unknown undesirable event.
    Type: Grant
    Filed: December 5, 2015
    Date of Patent: May 21, 2019
    Assignee: ThetaRay Ltd.
    Inventor: David Segev
  • Patent number: 10148680
    Abstract: A computer program product for performing anomaly detection, a detected anomaly being indicative of an undesirable event, the computer program product comprising a non-transitory tangible storage medium readable by a processing circuit and storing instructions for execution by the processing circuit for performing a method comprising receiving data comprising a plurality m of multidimensional datapoints (MDDPs), each data point having n features, constructing a dictionary D based on the received data, embedding dictionary D into a lower dimension embedded space and classifying, based in the lower dimension embedded space, an MDDP as an anomaly or as normal.
    Type: Grant
    Filed: June 15, 2016
    Date of Patent: December 4, 2018
    Assignee: ThetaRay Ltd.
    Inventors: David Segev, Gil Shabat
  • Patent number: 9942254
    Abstract: Method and system for detecting an unknown undesirable event, such as (but not limited to) a cyber-threat, a cyber-intrusion, a financial fraud event or a monitored process malfunction of breakdown. An exemplary method embodiments comprises obtaining a dataset comprising a plurality n of multidimensional data points with a dimension m?2 wherein each data point is a vector of m features, processing the MDPs using measure-based diffusion maps to embed the MDPs into a lower dimension embedded space, and detecting in the embedded space an abnormal MDP without relying on a signature of a threat, the abnormal MDP being indicative of the unknown undesirable event.
    Type: Grant
    Filed: July 10, 2015
    Date of Patent: April 10, 2018
    Assignee: ThetaRay Ltd.
    Inventors: Amir Averbuch, Gil Shabat, Erez Shabat, David Segev
  • Patent number: 9822134
    Abstract: The present invention relates to a novel delivery system for delivering therapeutic agents into living cells, and more particularly, to novel chemical moieties that are designed capable of targeting and/or penetrating cells or other targets of interest and further capable of binding therapeutic agents to be delivered to these cells, and to delivery systems containing same.
    Type: Grant
    Filed: April 20, 2015
    Date of Patent: November 21, 2017
    Assignee: SABAG-RFA LTD.
    Inventor: David Segev
  • Patent number: 9556210
    Abstract: The present invention relates to a novel delivery system for delivering therapeutic agents into living cells, and more particularly, to novel chemical moieties that are designed capable of targeting and/or penetrating cells or other targets of interest and further capable of binding therapeutic agents to be delivered to these cells, and to delivery systems containing same.
    Type: Grant
    Filed: April 20, 2015
    Date of Patent: January 31, 2017
    Assignee: SABAG-RFA LTD.
    Inventor: David Segev
  • Publication number: 20160176903
    Abstract: The present invention relates to a novel delivery system for delivering therapeutic agents into living cells, and more particularly, to novel chemical moieties that are designed capable of targeting and/or penetrating cells or other targets of interest and further capable of binding therapeutic agents to be delivered to these cells, and to delivery systems containing same.
    Type: Application
    Filed: April 20, 2015
    Publication date: June 23, 2016
    Inventor: David SEGEV
  • Publication number: 20160039850
    Abstract: The present invention relates to a novel delivery system for delivering therapeutic agents into living cells, and more particularly, to novel chemical moieties that are designed capable of targeting and/or penetrating cells or other targets of interest and further capable of binding therapeutic agents to be delivered to these cells, and to delivery systems containing same.
    Type: Application
    Filed: April 20, 2015
    Publication date: February 11, 2016
    Inventor: David Segev
  • Patent number: 9156865
    Abstract: The present invention relates to a novel delivery system for delivering therapeutic agents into living cells, and more particularly, to novel chemical moieties that are designed capable of targeting and/or penetrating cells or other targets of interest and further capable of binding therapeutic agents to be delivered to these cells, and to delivery systems containing same.
    Type: Grant
    Filed: October 22, 2012
    Date of Patent: October 13, 2015
    Assignee: DELIVERSIR LTD
    Inventor: David Segev
  • Patent number: 8680062
    Abstract: A novel class of oligomeric compounds designed for forming conjugates with biologically active substances and delivering these substances to a desired bodily target are disclosed. Novel conjugates of these oligomeric compounds and biologically active moieties, pharmaceutical compositions containing such conjugates, and uses thereof as delivery systems for delivering the biologically active substances to a desired target are further disclosed. Processes of preparing the conjugates and the oligomeric compounds and novel intermediates designed for and used in these processes are also disclosed.
    Type: Grant
    Filed: June 1, 2007
    Date of Patent: March 25, 2014
    Assignee: Deliversir Ltd.
    Inventor: David Segev
  • Patent number: 8293209
    Abstract: The present invention relates to a novel delivery system for delivering therapeutic agents into living cells, and more particularly, to novel chemical moieties that are designed capable of targeting and/or penetrating cells or other targets of interest and further capable of binding therapeutic agents to be delivered to these cells, and to delivery systems containing same.
    Type: Grant
    Filed: October 22, 2009
    Date of Patent: October 23, 2012
    Assignee: Segev Laboratories Limited
    Inventor: David Segev
  • Publication number: 20100092386
    Abstract: The present invention relates to a novel delivery system for delivering therapeutic agents into living cells, and more particularly, to novel chemical moieties that are designed capable of targeting and/or penetrating cells or other targets of interest and further capable of binding therapeutic agents to be delivered to these cells, and to delivery systems containing same.
    Type: Application
    Filed: October 22, 2009
    Publication date: April 15, 2010
    Inventor: David SEGEV
  • Patent number: 7683164
    Abstract: A compound which comprises a backbone having a plurality of chiral carbon atoms, the backbone bearing a plurality of ligands each being individually bound to a chiral carbon atom of the plurality of chiral carbon atoms, the ligands including one or more pair(s) of adjacent ligands each containing a moiety selected from the group consisting of a naturally occurring nucleobase and a nucleobase binding group, wherein moieties of the one or more pair(s) are directly linked to one another via a linker chain; building blocks for synthesizing the compound; and uses of the compound, particularly in antisense therapy.
    Type: Grant
    Filed: February 19, 2008
    Date of Patent: March 23, 2010
    Assignee: Bio-Rad Laboratories Inc.
    Inventor: David Segev
  • Publication number: 20090005334
    Abstract: A compound which comprises a backbone having a plurality of chiral carbon atoms, the backbone bearing a plurality of ligands each being individually bound to a chiral carbon atom of the plurality of chiral carbon atoms, the ligands including one or more pair(s) of adjacent ligands each containing a moiety selected from the group consisting of a naturally occurring nucleobase and a nucleobase binding group, wherein moieties of the one or more pair(s) are directly linked to one another via a linker chain; building blocks for synthesizing the compound; and uses of the compound, particularly in antisense therapy.
    Type: Application
    Filed: February 19, 2008
    Publication date: January 1, 2009
    Applicant: Bio-Rad Laboratories Inc.
    Inventor: David Segev
  • Patent number: 7348148
    Abstract: A compound which comprises a backbone having a plurality of chiral carbon atoms, the backbone bearing a plurality of ligands each being individually bound to a chiral carbon atom of the plurality of chiral carbon atoms, the ligands including one or more pair(s) of adjacent ligands each containing a moiety selected from the group consisting of a naturally occurring nucleobase and a nucleobase binding group, wherein moieties of the one or more pair(s) are directly linked to one another via a linker chain; building blocks for synthesizing the compound; and uses of the compound, particularly in antisense therapy.
    Type: Grant
    Filed: March 2, 2006
    Date of Patent: March 25, 2008
    Assignee: Bio-Rad Laboratories Inc.
    Inventor: David Segev
  • Publication number: 20080004234
    Abstract: A novel class of oligomeric compounds designed for forming conjugates with biologically active substances and delivering these substances to a desired bodily target are disclosed. Novel conjugates of these oligomeric compounds and biologically active moieties, pharmaceutical compositions containing such conjugates, and uses thereof as delivery systems for delivering the biologically active substances to a desired target are further disclosed. Processes of preparing the conjugates and the oligomeric compounds and novel intermediates designed for and used in these processes are also disclosed.
    Type: Application
    Filed: June 1, 2007
    Publication date: January 3, 2008
    Applicant: Segev Laboratories Limited
    Inventor: David Segev
  • Publication number: 20060160763
    Abstract: A novel class of oligomeric compounds designed for forming conjugates with biologically active substances and delivering these substances to a desired bodily target are disclosed. Novel conjugates of these oligomeric compounds and biologically active moieties, pharmaceutical compositions containing such conjugates, and uses thereof as delivery systems for delivering the biologically active substances to a desired target are further disclosed. Processes of preparing the conjugates and the oligomeric compounds and novel intermediates designed for and used in these processes are also disclosed.
    Type: Application
    Filed: December 29, 2005
    Publication date: July 20, 2006
    Inventor: David Segev
  • Publication number: 20060148751
    Abstract: A compound which comprises a backbone having a plurality of chiral carbon atoms, the backbone bearing a plurality of ligands each being individually bound to a chiral carbon atom of the plurality of chiral carbon atoms, the ligands including one or more pair(s) of adjacent ligands each containing a moiety selected from the group consisting of a naturally occurring nucleobase and a nucleobase binding group, wherein moieties of the one or more pair(s) are directly linked to one another via a linker chain; building blocks for synthesizing the compound; and uses of the compound, particularly in antisense therapy.
    Type: Application
    Filed: March 2, 2006
    Publication date: July 6, 2006
    Applicant: Bio-Rad Laboratories Inc.
    Inventor: David Segev
  • Patent number: 7034131
    Abstract: A compound which comprises a backbone having a plurality of chiral carbon atoms, the backbone bearing a plurality of ligands each being individually bound to a chiral carbon atom of the plurality of chiral carbon atoms, the ligands including one or more pair(s) of adjacent ligands each containing a moiety selected from the group consisting of a naturally occurring nucleobase and a nucleobase binding group, wherein moieties of the one or more pair(s) are directly linked to one another via a linker chain; building blocks for synthesizing the compound; and rises of the compound, particularly in antisense therapy.
    Type: Grant
    Filed: January 29, 2002
    Date of Patent: April 25, 2006
    Assignee: Bio-Rad Laboratories Inc.
    Inventor: David Segev